Albott, C., Lee, S., Cullen, K., Thuras, P., Lissek, S., Wels, J., Friedrich, K., Krueger, A., Lim, K., 2021. Characterization of Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder Using Ketamine as an Experimental Medicine Probe. Journal of Psychiatry and Brain Science, 3 (6)
doi: https://doi.org/10.20900/jpbs.20210012
PubMed ID: 34632081
Shiroma, P. R., Thuras, P., Wels, J., Albott, C. S., Erbes, C., Tye, S., Lim, K. O., 2020. Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression. Journal of affective disorders, 227: 470-477.
doi: https://doi.org/10.1016/j.jad.2020.08.058
PubMed ID: 32871537
Thai, M., Başgöze, Z., Klimes-Dougan, B., Mueller, B. A., Fiecas, M., Lim, K. O., Albott, C. S., Cullen, K. R., 2020. Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression. Frontiers in Psychiatry, 11 (820)
doi: https://doi.org/10.3389/fpsyt.2020.00820
PubMed ID: 33013493
Roy, A., Thai, M., Klimes-Dougan, B., Westlund Schreiner, M., Mueller, B., Albott, C., Lim, K., Roback, M., Fiecas, M., Tye, S., Cullen, K., 2020. Neuroplasticity markers of clinical response to ketamine in adolescents with treatment-resistant depression: Entropy and insulin-dependent mTOR activation. Journal of Psychopharmacology, 35 (2): 168-177.
doi: https://doi.org/10.1177/0269881120928203
PubMed ID: 32643995
Albott, C. S., Wozniak, J. R., McGlinch, B. P., Wall, M. H., Gold, B. S., Vinogradov, S., 2020. Battle Buddies: Rapid Deployment of a Psychological Resilience Intervention for Health Care Workers During the COVID-19 Pandemic. Anesthesia & Analgesia, 131 (1): 43-54.
doi: https://doi.org/10.1213/ANE.0000000000004912
PubMed ID: 32345865
Shiroma, P. R., Thuras, P., Wels, J., Albott, C. S., Erbes, C., Tye, S., Lim, K. O., 2020. A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression. Translational Psychiatry, 10 (1)
doi: https://doi.org/10.1038/s41398-020-00897-0
PubMed ID: 32591496
Albott, C. S., Forbes, M. K., Anker, J. J., 2018. Association of Childhood Adversity With Differential Susceptibility of Transdiagnostic Psychopathology to Environmental Stress in Adulthood. JAMA network open, 1 (7)
doi: http://dx.doi.org/10.1001/jamanetworkopen.2018.5354
PubMed ID: 30646399
Cullen, K. R., Amatya, P., Roback, M. G., Albott, C. S., Westlund Schreiner, M., Ren, Y., Eberly, L. E., Carstedt, P., Samikoglu, A., Gunlicks-Stoessel, M., Reigstad, K., Horek, N., Tye, S., Lim, K. O., Klimes-Dougan, B., 2018. Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study. Journal of Child and Adolescent Psychopharmacology, 28 (7): 437-444.
doi: https://doi.org/10.1089/cap.2018.0030
PubMed ID: 30004253
Shiroma, P. R., Albott, C. S., Johns, B., Thuras, P., Wels, J., Lim, K. O., 2015. The Effect of Repeated Ketamine Infusion Over Facial Emotion Recognition in Treatment-Resistant Depression: A Preliminary Report. The Journal of Neuropsychiatry and Clinical Neurosciences, 27 (4): 362-364.
doi: https://doi.org/10.1176/appi.neuropsych.14100243
PubMed ID: 25658681
Albott, C. S., Lim, K. O., Forbes, M. K., Erbes, C., Tye, S. J., Grabowski, J. G., Thuras, P., Batres-Y-Carr, T. M., Wels, J., Shiroma, P. R., 2018. Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression. The Journal of Clinical Psychiatry, 79 (3)
doi: http://dx.doi.org/10.4088/JCP.17m11634
PubMed ID: 29727073